Biogen Pharmachem Industries Ltd Share Price Today - Biogen Pharmachem Industries Ltd Stock Price Live NSE/BSE

Biogen Pharmachem Industries Ltd

NSE: BSE: 531752

₹0.54

(0%)

Sat, 21 Mar 2026, 07:44 pm

MTF 5xInvest in Biogen Pharmachem Industries Ltd with 5x Leverage Buy with MTF

Market Cap487.41M

PE Ratio16.56

Dividend0

Finance

Investment Banks/Brokers

24.5K

Biogen Pharmachem Industries Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
48.74
Net Profit
-0.29
P/B
1.12
Sector P/E
22.46
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
1.85
Interest Cover (Industry)
1.58
ROCE (Industry)
8.32
RONW (Industry)
7.05
ROE
0
ROCE
0
Debt/Equity
0
EPS (TTM)
0.03
Dividend Yield
0
Book Value
1.10
Interest Cover
0

Analysis

all

Pros

Sun Techno Overseas is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Debt is covered by short term assets, assets are 12.6x debt.
Sun Techno Overseas's cash and other short term assets cover its long term commitments.
The level of debt compared to net worth has been reduced over the past 5 years (119.2% vs 1.2% today).
Sun Techno Overseas's level of debt (1.2%) compared to net worth is satisfactory (less than 40%).

Cons

Unable to evaluate Sun Techno Overseas's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Sun Techno Overseas's dividend against the top 25% market benchmark as the company has not reported any payouts.
Debt is not well covered by operating cash flow (13.7%, less than 20% of total debt).
The average tenure for the Sun Techno Overseas board of directors is less than 3 years, this suggests a new board.
Sun Techno Overseas is not covered by any analysts.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	0	0	0	0	0
FII	0	0	0	0	0
DII	0.00	0.00	0.00	0.00	0.00
Public	100.00	100.00	100.00	100.00	100.00
Government	0	0	0	0	0

Technical Analysis

RSI

19.77

MACD

-0.03

50 DMA

0.65

200 DMA

0.81

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	1.20	0.95	0.81	0.70	0.56	0.45	0.20
Fibonacci	0.95	0.85	0.80	0.70	0.60	0.55	0.45
Camarilla	0.74	0.72	0.69	0.70	0.65	0.62	0.60

Pivots Level: Classic

+0.50

1.20

+0.25

0.95

+0.11

0.81

0.70

Pivot Point

LTP: 0.54

-0.14

0.56

-0.25

0.45

-0.50

0.20

Moving Average

SMAEMA

Period

Value

10-EMA
0.58
20-EMA
0.61
30-EMA
0.63
50-EMA
0.65
100-EMA
0.70
200-EMA
0.79

Announcement Date	Purpose	Action
11 Feb 2026	board-meetings	Quarterly Results
03 Feb 2026	board-meetings	Quarterly Results
07 Nov 2025	board-meetings	Quarterly Results
25 Aug 2025	agm
13 Sept 2024	agm
10 Jan 2024	egm
21 Sept 2023	agm
05 Sept 2022	agm
27 Aug 2021	agm

Biogen Pharmachem Industries Ltd

Jio Financial Services Ltd

Bajaj Finserv Ltd

Power Finance Corporation Ltd

Shriram Finance Ltd

Bajaj Finance Ltd

Biogen Pharmachem Industries Ltd About

Biogen Pharmachem Industries is engaged in the financial services sector, including trading in shares, securities, and commodities.

Industry

Finance & Investments

Founded

1995

Headquarters

CEO

Employees

Contact

Website

http://www.biogenpharma.shop

suntechnooverseas@gmail.com

Phone

91-79-27498832

Location

Shop No 8 First Floor, Makers 1 Building Jawahar Road, Rajkot, Gujarat, 360001

Year	History
2008	Mr. Hiteshbhai Natvarlal Parikh was appointed as an Additional Director of the company.
2009	The company's registered office was shifted from 408, 4th Floor, Saman Complex, Opp: Nalanda Complex, Near Star Apartment, Jodhpur Road, Satellite, Ahmedabad-380015 to 603, 6th Floor, Pratiksha Complex, Near Mahalaxmi Five Roads, Paldi, Ahmedabad -380007.
2011	The company changed its name from Wellworth Overseas Ltd. to Sun Techno Overseas Ltd.
2012	The company's registered office was shifted to 320, Vrundavan Enclave, Near Reliance Petrol Pump, 132ft Ring Road, Near AEC Cross Road, Naranpura Ahmedabad - 380013.
2021	The company changed its name from Sun Techno Overseas to Biogen Pharmachem Industries Ltd.

Client Name	Order Side	QTY	Avg Price	Date
TOPGAIN FINANCE PRIVATE LIMITED	Sell	3355000	1.3	10 Jul 2024
TOPGAIN FINANCE PRIVATE LIMITED	Buy	4440901	1.44	09 Jul 2024
TOPGAIN FINANCE PRIVATE LIMITED	Sell	1085901	1.44	09 Jul 2024
JAI VINAYAK SECURITIES	Buy	3274609	1.72	05 Jul 2024
JAI VINAYAK SECURITIES	Sell	3620035	1.7	05 Jul 2024
TOPGAIN FINANCE PRIVATE LIMITED	Buy	3780832	1.23	03 Jul 2024
TOPGAIN FINANCE PRIVATE LIMITED	Sell	3780832	1.23	03 Jul 2024
SAHASTRAA ADVISORS PRIVATE LIMITED	Sell	3291682	1.25	03 Jul 2024
SAHASTRAA ADVISORS PRIVATE LIMITED	Buy	3778839	1.23	03 Jul 2024
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Sell	3388048	1.38	02 Jan 2024

Biogen Pharmachem Industries Ltd News

Biogen Pharmachem Board to Consider Bonus Shares

Biogen Pharmachem Industries Limited has scheduled a board meeting for March 23, 2026, to consider declaring bonus shares, subject to shareholder approval under SEBI regulations.

24 Feb 2026

co actions results

Biogen Pharmachem Board Meet Set for Feb 3, 2026

Biogen Pharmachem Industries Limited has scheduled a board meeting on February 3, 2026, to consider and approve Q3FY26 unaudited financial results for the quarter and nine months ended December 31, 2025.

19 Jan 2026

stocks

Biogen Pharmachem Submits Q3FY26 SEBI Certificate

Biogen Pharmachem Industries Limited submitted its quarterly certificate under SEBI Regulation 74(5) for Q3FY26 ended December 31, 2025, with no physical shares received for dematerialization during the quarter.

05 Jan 2026

stocks

Biogen Pharmachem Industries Reports Quarterly Financial Results for September 2025

Biogen Pharmachem Industries Limited announced its unaudited financial results for the quarter and half year ended September 30, 2025. The company reported total income of Rs 1.58 lakh and net profit after tax of Rs 0.85 lakh for the quarter. For the half year period, total income was Rs 1.44 lakh with net profit after tax of Rs 0.92 lakh. The company's equity share capital stands at Rs 90.26 crore. The board meeting was held on November 7, 2025, where directors approved the financial results. The company operates in a single business segment and has its registered office in Rajkot. The financial results were reviewed by statutory auditors who conducted a limited review of the statements.

07 Nov 2025

earnings

Biogen Pharmachem Industries Reports Turnaround with Rs 134.48 Lakh Net Profit in Q1

Biogen Pharmachem Industries Limited reported a net profit of Rs 134.48 lakhs for the quarter ended June 30, 2025, marking a significant turnaround from a loss of Rs 15.83 lakhs in the same quarter last year. The company's revenue from operations increased to Rs 154.28 lakhs compared to negative Rs 9.09 lakhs in the previous year quarter. Total expenses rose to Rs 19.80 lakhs from Rs 6.73 lakhs, primarily due to higher employee benefit expenses and other expenses. The company's paid-up equity share capital increased to Rs 9,026.03 lakhs from Rs 6,526.03 lakhs. Basic and diluted earnings per share stood at Rs 0.01. The Board of Directors approved these unaudited financial results in their meeting held on July 23, 2025.

23 Jul 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800